Skip to main content
. Author manuscript; available in PMC: 2015 Jan 28.
Published in final edited form as: Cancer Lett. 2014 Oct 7;356(0):454–461. doi: 10.1016/j.canlet.2014.09.043

Figure 4.

Figure 4

Bystander BRCA1 (A) and FANCD2 foci (B) in T98G cells, T98G treated with the specific ATM inhibitor (ATMi) KU55933 at 10 μM or the ATR/ATM inhibitor caffeine at 1 mM, as well as in GM05849 AT cells and in ATR mutated FO2-98 hTERT cells. Foci counts in control samples were subtracted. Bars represent average induced foci per cell; error bars show SEM from 3-5 experiments.